trial · primary record
Sibeprenlimab
IgA Nephropathy
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2028-12-28 |
| Primary endpoint | Change from Baseline in Glomerular IgA Deposition by Immunofluorescence in Kidney Tissue to Week 52 |
| Registry ID | NCT06740526 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:49.509Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06740526
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.